libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - Önnur lyf í taugakerfinu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
pregabalin krka hart hylki 300 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 300 mg
pregabalin medical valley hart hylki 25 mg
medical valley invest ab - pregabalinum inn - hart hylki - 25 mg
pregabalin krka hart hylki 225 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 225 mg
pregabalin medical valley hart hylki 75 mg
medical valley invest ab - pregabalinum inn - hart hylki - 75 mg
brieka hart hylki 150 mg
teva b.v.* - pregabalinum inn - hart hylki - 150 mg
brieka hart hylki 75 mg
teva b.v.* - pregabalinum inn - hart hylki - 75 mg
pregabalin medical valley hart hylki 150 mg
medical valley invest ab - pregabalinum inn - hart hylki - 150 mg
brieka hart hylki 300 mg
teva b.v.* - pregabalinum inn - hart hylki - 300 mg
alprazolam wh (alprazolam mylan) tafla 0,25 mg
williams & halls ehf - alprazolamum inn - tafla - 0,25 mg